LINC00868: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC00868

NCBI ID: G283994

LINC00868

Other Name(s): long intergenic non-protein coding RNA 868 | C17orf52 | Long intergenic non-protein coding RNA 868, transcript variant 1

LINC00868: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC00868 is a long non-coding RNA (lncRNA) that has been identified in various studies as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells, including brain, heart, and muscle. LINC00868 has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and survival.

Drug Target Potential

LINC00868 has been identified as a potential drug target due to its unique structure and its expressed levels in various tissues. It is a long RNA molecule that has a length of approximately 21 kilobases (kb), which makes it a potential drug target that can be targeted by small molecules. Additionally, LINC00868 is expressed in a variety of tissues, which means that it is a potential biomarker for various diseases.

Biomarker Potential

LINC00868 has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and survival. It has been shown to be involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and function. Additionally, LINC00868 has been shown to be involved in the regulation of cell migration, which is critical for the development and maintenance of tissues and organs.

Expression and Measurement

LINC00868 has been shown to be expressed in a variety of tissues and cells, including brain, heart, and muscle. It has been shown to be expressed at different levels in different tissues, which suggests that it may play a role in the regulation of various cellular processes at different stages of development.

Methods to Measure LINC00868 Expression

There are several techniques that can be used to measure LINC00868 expression, including qRT-PCR, western blotting, and immunofluorescence. These techniques can be used to detect the expression of LINC00868 in different tissues and cells, and can be used to assess its level of expression.

Conclusion

LINC00868 is a long non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and its expressed levels in various tissues make it a potential target for small molecules. Additionally, its involvement in the regulation of various cellular processes, including cell adhesion and migration, makes it a potential biomarker for various diseases. Further research is needed to fully understand the role of LINC00868 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 868

The "LINC00868 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00868 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets